FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015641383> ?p ?o ?g. }

• W2015641383 endingPage "42" @default.
• W2015641383 startingPage "35" @default.
• W2015641383 abstract "We analyzed the antiplatelet effects of different P2Y12 receptor blockers with VerifyNow P2Y12 assay (VN-P2Y12) and light transmittance aggregometry (LTA). The point-of-care VN-P2Y12 has been used to assess the antiplatelet effects in clopidogrel-treated patients but has not been evaluated in detail in patients treated with ticagrelor. Patients were randomly assigned to either ticagrelor [180 mg loading/90 mg twice daily (n = 37)] or clopidogrel [600 mg loading/75 mg daily (n = 39)] on top of aspirin treatment, and platelet reactivity was measured serially during onset, maintenance, and offset phases. High on-treatment platelet reactivity (HPR) was defined as 5 and 20 μM adenosine diphosphate-induced maximal platelet aggregation ≥46% and ≥59%, respectively, and P2Y12 reaction units ≥235. Platelet function measured by VN-P2Y12 correlated well with LTA (.812 ≤ ρ ≤ .823, P < .001). VN-P2Y12 “BASE” values were consistent during administration of both agents. Calculated and reported percent inhibitions by VN-P2Y12 were similar (difference, −0.6%; 95% agreement limits, −22.9% to 21.6%). Platelet inhibition by VN-P2Y12 during clopidogrel and ticagrelor administrations was comparable to platelet inhibition by LTA. HPR determined by LTA and VN-P2Y12 were well matched, and the risk stratification between the two methods showed strong agreement after both therapies (κ > .7). The VerifyNow P2Y12 assay is effective in assessing the antiplatelet effects and in identifying HPR during clopidogrel or ticagrelor therapy." @default.
• W2015641383 created "2016-06-24" @default.
• W2015641383 creator A5007372093 @default.
• W2015641383 creator A5011626347 @default.
• W2015641383 creator A5012918602 @default.
• W2015641383 creator A5037954844 @default.
• W2015641383 creator A5039130551 @default.
• W2015641383 creator A5085491969 @default.
• W2015641383 date "2012-07-01" @default.
• W2015641383 modified "2023-10-03" @default.
• W2015641383 title "Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies" @default.
• W2015641383 cites W18470154 @default.
• W2015641383 cites W1972045176 @default.
• W2015641383 cites W1974655135 @default.
• W2015641383 cites W2000559729 @default.
• W2015641383 cites W2008053743 @default.
• W2015641383 cites W2013560303 @default.
• W2015641383 cites W2015795623 @default.
• W2015641383 cites W2033401592 @default.
• W2015641383 cites W2058217708 @default.
• W2015641383 cites W2072518791 @default.
• W2015641383 cites W2073268191 @default.
• W2015641383 cites W2087149561 @default.
• W2015641383 cites W2092916613 @default.
• W2015641383 cites W2099022345 @default.
• W2015641383 cites W2118791457 @default.
• W2015641383 cites W2119929689 @default.
• W2015641383 cites W2124949187 @default.
• W2015641383 cites W2141883929 @default.
• W2015641383 cites W2149465085 @default.
• W2015641383 cites W2157214128 @default.
• W2015641383 cites W2157833432 @default.
• W2015641383 cites W2161055506 @default.
• W2015641383 cites W2165620610 @default.
• W2015641383 cites W2170056615 @default.
• W2015641383 cites W2170312517 @default.
• W2015641383 cites W2171807722 @default.
• W2015641383 cites W29404186 @default.
• W2015641383 cites W2968751749 @default.
• W2015641383 cites W67811773 @default.
• W2015641383 doi "https://doi.org/10.1016/j.ahj.2012.03.022" @default.
• W2015641383 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22795280" @default.
• W2015641383 hasPublicationYear "2012" @default.
• W2015641383 type Work @default.
• W2015641383 sameAs 2015641383 @default.
• W2015641383 citedByCount "74" @default.
• W2015641383 countsByYear W20156413832013 @default.
• W2015641383 countsByYear W20156413832014 @default.
• W2015641383 countsByYear W20156413832015 @default.
• W2015641383 countsByYear W20156413832016 @default.
• W2015641383 countsByYear W20156413832017 @default.
• W2015641383 countsByYear W20156413832018 @default.
• W2015641383 countsByYear W20156413832019 @default.
• W2015641383 countsByYear W20156413832020 @default.
• W2015641383 countsByYear W20156413832021 @default.
• W2015641383 countsByYear W20156413832022 @default.
• W2015641383 countsByYear W20156413832023 @default.
• W2015641383 crossrefType "journal-article" @default.
• W2015641383 hasAuthorship W2015641383A5007372093 @default.
• W2015641383 hasAuthorship W2015641383A5011626347 @default.
• W2015641383 hasAuthorship W2015641383A5012918602 @default.
• W2015641383 hasAuthorship W2015641383A5037954844 @default.
• W2015641383 hasAuthorship W2015641383A5039130551 @default.
• W2015641383 hasAuthorship W2015641383A5085491969 @default.
• W2015641383 hasConcept C126322002 @default.
• W2015641383 hasConcept C164705383 @default.
• W2015641383 hasConcept C2777028646 @default.
• W2015641383 hasConcept C2777399203 @default.
• W2015641383 hasConcept C2777628954 @default.
• W2015641383 hasConcept C2777849778 @default.
• W2015641383 hasConcept C2780890252 @default.
• W2015641383 hasConcept C2993802102 @default.
• W2015641383 hasConcept C35294091 @default.
• W2015641383 hasConcept C49059817 @default.
• W2015641383 hasConcept C71924100 @default.
• W2015641383 hasConcept C89560881 @default.
• W2015641383 hasConcept C98274493 @default.
• W2015641383 hasConceptScore W2015641383C126322002 @default.
• W2015641383 hasConceptScore W2015641383C164705383 @default.
• W2015641383 hasConceptScore W2015641383C2777028646 @default.
• W2015641383 hasConceptScore W2015641383C2777399203 @default.
• W2015641383 hasConceptScore W2015641383C2777628954 @default.
• W2015641383 hasConceptScore W2015641383C2777849778 @default.
• W2015641383 hasConceptScore W2015641383C2780890252 @default.
• W2015641383 hasConceptScore W2015641383C2993802102 @default.
• W2015641383 hasConceptScore W2015641383C35294091 @default.
• W2015641383 hasConceptScore W2015641383C49059817 @default.
• W2015641383 hasConceptScore W2015641383C71924100 @default.
• W2015641383 hasConceptScore W2015641383C89560881 @default.
• W2015641383 hasConceptScore W2015641383C98274493 @default.
• W2015641383 hasIssue "1" @default.
• W2015641383 hasLocation W20156413831 @default.
• W2015641383 hasLocation W20156413832 @default.
• W2015641383 hasOpenAccess W2015641383 @default.
• W2015641383 hasPrimaryLocation W20156413831 @default.
• W2015641383 hasRelatedWork W1536222796 @default.
• W2015641383 hasRelatedWork W2094353400 @default.
• W2015641383 hasRelatedWork W2114290874 @default.

• next